Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Certified by Founder
Lodge
Umoja Biopharma
start up
United States
- Seattle, Washington
- 21/01/2025
- Series C
- $100,000,000
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies
- Industry Biotechnology Research
- Website https://www.umoja-biopharma.com/
- LinkedIn https://www.linkedin.com/company/umoja-biopharma/
Related People
Andy ScharenbergFounder
United States -
Seattle, Washington
Physician, Scientist, Entrepreneur, passionate about the impact that CAR T-cells can have on the treatment of cancer.
Carbon(US) | $60,000,000 | (Nov 14, 2025)
Big Rentals | $2,800,000 | (Nov 14, 2025)
Bindwell | $6,000,000 | (Nov 14, 2025)
Anzen Insurance | $16,000,000 | (Nov 14, 2025)
Beacon Biosignals | $86,000,000 | (Nov 14, 2025)
Fabric8Labs | $50,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
sunday (US) | $21,000,000 | (Nov 14, 2025)
Maybern | $50,000,000 | (Nov 14, 2025)